Home >

Events >

Community >

Podcast >

Sponsors  >

About Us >

Contacts >

Dr Sven Jungmann – Halitus

Jan 24, 2024 | Uncategorized

Sven Jungmann, CEO of Halitus, discusses the potential of breath analysis in healthcare and the challenges involved. He explains the technology behind breath analysis and the difficulty of determining baselines and analyzing molecules. Sven also shares his experiences with funding and grants, highlighting the differences between Europe and the US. He emphasizes the importance of starting with first principles and understanding the complexities of healthcare. Sven concludes by discussing the need for more innovation and risk-taking in the healthcare industry. The conversation explores various topics in the field of MedTech and healthcare innovation. It discusses the changing landscape of drug manufacturing and sales, the importance of diagnostics and preventive medicine, the role of AI in healthcare, the potential of breath testing in disease detection, and the challenges of implementing AI in healthcare. The conversation also touches on the limitations of using dogs for disease detection, the serendipitous nature of scientific discoveries, and the excitement of physical products in MedTech. The episode concludes with information on the future of MedTech and contact details for further inquiries.


  • Breath analysis has the potential to provide valuable insights into various health conditions.
  • Analyzing breath is challenging due to the complexity of molecules and the need to determine baselines.
  • Funding and grants can be difficult to obtain, especially in Europe, where there is a lack of risk-taking.
  • Investors should focus on first principles and deep understanding when evaluating healthcare startups.
  • There is a need for more innovation and collaboration in the healthcare industry. The healthcare industry is undergoing changes in drug manufacturing and sales, with some companies adopting new models that focus on manufacturing drugs at cost.
  • Diagnostics and preventive medicine play a crucial role in improving patient outcomes and reducing preventable diseases.
  • AI has the potential to revolutionize healthcare by optimizing signal-to-noise ratios, analyzing continuous data, and predicting disease complications.
  • Breath testing shows promise as a non-invasive method for disease detection, offering potential benefits over traditional invasive tests.
  • Implementing AI in healthcare poses challenges, including the need for evidence-based decision-making and adjusting guidelines to accommodate new data sources.
  • Using dogs for disease detection has limitations in terms of scalability, cost, and explainability.
  • Serendipitous discoveries and collaborative research can lead to breakthroughs in medical innovation.
  • The development of physical products in MedTech can provide gratification and tangible impact.
  • The future of MedTech holds exciting possibilities, including personalized medicine and data-driven biogas, but requires long-term commitment and passionate investors.

The Startup Events